Thermo Scientific Elects New Director to Board
News Mar 26, 2012
Thermo Fisher Scientific Inc. has announced that C. Martin Harris, MD, MBA, has been elected to its board of directors, effective March 30, bringing the company’s total number of directors to 13.
Dr. Harris has also been appointed to the board’s Nominating and Governance Committee.
Dr. Harris is the chief information officer and chairman of the information technology division of Cleveland Clinic in Ohio, one of the nation’s largest hospitals.
Additionally, he is responsible for strategic business planning for Cleveland Clinic.
Dr. Harris’ interest and expertise in improving the practice of medicine through the innovative application of information technology is reflected in his serving on numerous national policy and technology organizations.
He was tapped by the U.S. Secretary of Health and Human Services to help draft the electronic health records mandate in the economic stimulus package and recruited to guide Microsoft Corporation on an innovative pilot in disease management.
“We are extremely pleased to welcome Dr. Harris to our board as a new independent director,” said Jim Manzi, chairman of the board of Thermo Fisher Scientific.
Manzi continued, “Given his extensive healthcare and information technology expertise, as well as his strong track record of innovation, he will provide unique and valuable perspective to Thermo Fisher as we continue to execute our strategy for long-term growth.”
Dr. Harris currently serves as a member of the board of Invacare Corporation, the global leader in the manufacture and distribution of home and long-term care medical products, and HealthStream, Inc., an Internet-based learning and research solutions provider for the healthcare industry.
Genes Can Influence the Mutation, Activity of Nearby GenesNews
Study shows that a gene’s neighborhood can influence whether and how the activity of a gene changes.READ MORE
Protein Discovery Could Lead to Better Diagnosis of StressNews
Researchers have found a protein that is present in people while they are in stressful situations. The discovery could lead to identifying new ways to predict, diagnose and treat stress.READ MORE
Enterome and Nestlé Health Sciences Launch New Diagnostics CompanyNews
Enterome and Nestlé Health Sciences join to create Microbiome Diagnostics Partners, a company that will enable the development and diagnostics for multiple diseases including inflammatory bowel diseases (IBD) and liver diseases.READ MORE